FDA Launches Interactive Summary of Biomass-Adjusted Antimicrobial Sales Data in Food Animals

Dec 06, 2022

The U.S. Food and Drug Administration launched an Interactive Summary of Biomass-Adjusted Antimicrobial Sales Data.

The display applies a biomass denominator to adjust existing annual antimicrobial sales and distribution data for medically important antimicrobial drugs sold or distributed for use in food-producing animals (cattle, swine, chickens, and turkeys) in the United States for years 2016 to 2020. Animal biomass is defined as the population of a given livestock species in the U.S. multiplied by the average weight of that species. In this method, a biomass denominator adjusts annual antimicrobial sales data to account for the size of the population of a given livestock species in the U.S. potentially being treated with those drugs.

See the interactive summary at https://www.fda.gov/animal-veterinary/antimicrobial-resistance/biomass-adjusted-antimicrobial-sales-and-distribution-data-food-producing-animals-interactive.

The interactive summary allows users to customize data visualizations using criteria such as antimicrobial drug class, species, and year.

Click here to see more...

Video: Season 6, Episode 10: Defining Resiliency and the Research Driving Swine Health Forward

Genetic research and new technologies continue to influence the future of swine health and production efficiency. In this episode, we explore how research and technology are being used to support stronger, more resilient pigs, while also improving overall production outcomes. In this episode, we are joined by Dr. Jenelle Dunkelberger, geneticist with Topigs Norsvin, to discuss both routine and emerging strategies for improving piglet, pig, and sow livability. She outlines two primary approaches to enhancing resiliency: gene editing and traditional selective breeding. Continuing the resiliency conversation, we also hear from Dr. Lucina Galina, director of technical research projects at the Pig Improvement Company. She shares insights into ongoing gene-editing work focused on PRRS, detailing the pathway to success, regulatory and practical considerations, and the questions that still remain as the technology evolves. Together, these conversations provide a closer look at how research, genetics and innovation are shaping the future of swine health and livability.